What We're Reading: Page 120
Industry reads hand-picked by our editors
Jun 22, 2022
Jun 21, 2022
-
Bloomberg
Forget Crypto Winter. In Biotech, It’s Been Freezing for Months
-
The Wall Street Journal
Can We Develop a Covid-19 Vaccine That Lasts?
-
BioSpace
Acadia's Alzheimer’s Drug Voted Down by FDA Advisory Committee
-
Nature Medicine
Four areas of health innovation boosted by the pandemic
Jun 17, 2022
Jun 16, 2022
-
MedCity News
November will bring political change. Will it also change drug prices and PDUFA?
-
The Washington Post
WHO to rename monkeypox after scientists call it ‘discriminatory’
-
Chemical & Engineering News
Molecular glue firms get investment, strike partnerships
-
Bloomberg
Goldman Backs Biotech Firm in Volatile Year for China Deals
Jun 15, 2022
-
FierceBiotech
BIO'22 marked by first-time handshakes and attempts at survival
-
The Atlantic
Monkeypox Vaccines Are Too Gnarly for the Masses
-
Financial Times
Investors bet on AI start-ups to turbocharge drug development
-
Associated Press
FDA advisers back Moderna's COVID-19 vaccine for older kids
Jun 14, 2022
-
Financial Times
BioNTech’s second act: can it transform the fight against cancer?
-
The Wall Street Journal
Lawmakers Make Bipartisan Push for New Government Powers to Block U.S. Investments in China
-
Fierce Biotech
Blade Therapeutics' SPAC merger is cancelled
-
San Francisco Business Times
Biotech industry pushes Congress to allow new incentive to help capital-hungry startups
Previous
